Alps-Advisors

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-04-30
Total Holdings
1,028
Total Value
17244920728
Accession Number
0001398344-25-008194
Form Type
13F-HR
Manager Name
Alps-Advisors
Data Enrichment
97% identified
996 identified32 unidentified

Holdings

1,028 positions • $17.2B total value
Manager:
Search and click to pin securities to the top
Page 50 of 50
ENANTA PHARMACEUTICALS INC
Shares:16.3K
Value:$89.7K
% of Portfolio:0.0% ($89.7K/$17.2B)
Zentalis Pharmaceuticals, Inc.
Shares:55.0K
Value:$87.5K
% of Portfolio:0.0% ($87.5K/$17.2B)
PROKIDNEY CORP.
Shares:95.2K
Value:$83.4K
% of Portfolio:0.0% ($83.4K/$17.2B)
Kyverna Therapeutics, Inc.
Shares:32.1K
Value:$62.0K
% of Portfolio:0.0% ($62.0K/$17.2B)
MACROGENICS INC
Shares:48.6K
Value:$61.8K
% of Portfolio:0.0% ($61.8K/$17.2B)
PLIANT THERAPEUTICS, INC.
Shares:45.3K
Value:$61.1K
% of Portfolio:0.0% ($61.1K/$17.2B)
Atlas Lithium Corp
Shares:10.8K
Value:$55.7K
% of Portfolio:0.0% ($55.7K/$17.2B)
Critical Metals Corp.
Shares:36.8K
Value:$51.2K
% of Portfolio:0.0% ($51.2K/$17.2B)
SUTRO BIOPHARMA, INC.
Shares:61.3K
Value:$39.9K
% of Portfolio:0.0% ($39.9K/$17.2B)
AMERICAN BATTERY TECHNOLOGY Co
Shares:30.0K
Value:$30.9K
% of Portfolio:0.0% ($30.9K/$17.2B)